Skip to content. | Skip to navigation

Personal tools

Navigation

CALIPSOplus OFFERS RAPID ACCESS FOR SMES AND COVID-19 PROJECTS

You are here: Home / MEDIA / NEWS / CALIPSOplus OFFERS RAPID ACCESS FOR SMES AND COVID-19 PROJECTS
With the support of the European project CALIPSOplus, SMEs companies working with COVID-19 projects are encouraged to apply access to light sources in an easy, rapid and confidential way. Interested companies can send the proposals using the "wayforlight.eu" portal. The current call is open till 29h July 2020.

Visit Way for Light to submit your proposal

Cerdanyola del Vallès, 4th May 2020  CALIPSOplus brings together 19 partners with the aim to remove barriers that prevent access to world-class accelerator based light sources. The intense beams generated by light sources are outstanding tools for characterizing a large type of materials that provides unique information very useful for industry.

CALIPSOplus, with TamaTA workpackage lead by the ALBA Industrial Liaison Office, will support SMEs working with COVID-19 projects for a rapid, easy and confidential access to light sources. TamaTA, an on-going tool for SMEs, has been adapted to fight the Sars-Cov-2 virus and contribute to the worldwide actions against this pandemic.

TamaTA allows to go beyond a simple feasibility access and to carry out a full experiment or set of experiments. To facilitate the access and to reduce costs, a remote access is foreseen based on sample mail-in without physical presence of the industrial researcher at the facility. In this way researchers from SMEs, normally with very tight budgets, will have the same access opportunities independently of their location within Europe and with respect to the light source. This access mode will be particularly valuable for SMEs located in countries without a national light source; whereas it will promote light sources use by SMEs located in regions around an existing light source. In addition, for non-expert SMEs, support for data analysis and interpretation will be offered.

 

IM-CALIPSOplus

 CALIPSOplus has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n. º 730872